REGULATION OF THE HUMAN ALTERNATIVE COMPLEMENT PATHWAY - FORMATION OF A TERNARY COMPLEX BETWEEN FACTOR-H, SURFACE-BOUND C3B AND CHEMICAL GROUPS ON NONACTIVATING SURFACES

被引:43
作者
CARRENO, MP
LABARRE, D
MAILLET, F
JOZEFOWICZ, M
KAZATCHKINE, MD
机构
[1] HOP BROUSSAIS,INSERM,U28,UNITE IMMUNOPATHOL,96 RUE DIDOT,F-75674 PARIS 14,FRANCE
[2] UNIV PARIS 13,CNRS,UA 502,F-93430 VILLETANEUSE,FRANCE
关键词
D O I
10.1002/eji.1830191126
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2145 / 2150
页数:6
相关论文
共 30 条
[1]  
ANDREZIK JA, 1985, RAT NERVOUS SYSTEM, V2, P1
[2]   THE ABILITY OF SEPHADEX TO ACTIVATE HUMAN-COMPLEMENT IS SUPPRESSED IN SPECIFICALLY SUBSTITUTED FUNCTIONAL SEPHADEX DERIVATIVES [J].
CARRENO, MP ;
LABARRE, D ;
JOZEFOWICZ, M ;
KAZATCHKINE, MD .
MOLECULAR IMMUNOLOGY, 1988, 25 (02) :165-171
[3]   SPECIFIC ANTIBODIES ENHANCE SEPHADEX-INDUCED ACTIVATION OF THE ALTERNATIVE COMPLEMENT PATHWAY IN HUMAN-SERUM [J].
CARRENO, MP ;
MAILLET, F ;
LABARRE, D ;
JOZEFOWICZ, M ;
KAZATCHKINE, MD .
BIOMATERIALS, 1988, 9 (06) :514-518
[4]   PROPERDIN - BINDING TO C3B AND STABILIZATION OF C3B-DEPENDENT C3 CONVERTASE [J].
FEARON, DT ;
AUSTEN, KF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 142 (04) :856-863
[5]  
FEARON DT, 1977, TRANSPL P, V9, P729
[6]   ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY DUE TO RESISTANCE OF ZYMOSAN-BOUND AMPLIFICATION CONVERTASE TO ENDOGENOUS REGULATORY MECHANISMS [J].
FEARON, DT ;
AUSTEN, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (04) :1683-1687
[7]   ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY WITH RABBIT ERYTHROCYTES BY CIRCUMVENTION OF REGULATORY ACTION OF ENDOGENOUS CONTROL PROTEINS [J].
FEARON, DT ;
AUSTEN, KF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (01) :22-33
[8]   REGULATION BY MEMBRANE SIALIC-ACID OF BETA-1H-DEPENDENT DECAY-DISSOCIATION OF AMPLIFICATION C3 CONVERTASE OF ALTERNATIVE COMPLEMENT PATHWAY [J].
FEARON, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (04) :1971-1975
[9]  
FISHELSON Z, 1982, J IMMUNOL, V129, P2603
[10]  
HORSTMANN RD, 1985, J IMMUNOL, V134, P1101